Skip to Content »

Site Map

FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

Available Formats Price
ePub eBook $99.00
(With Adobe DRM, readable with Adobe Digital Editions for PCs and Macs, and on most mobile devices except Kindle)
PDF eBook $99.00
(With Adobe DRM, readable with Adobe Digital Editions for PCs and Macs, and on most mobile devices except Kindle)
Print - Hardback $99.00

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.

Author Information

    By Jack Cush and Kathryn H. Dao

Customer Reviews

Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
  • e-Book
  • Imprint: Saunders
  • Copyright: 2012